Invitria

Recombinant, Animal-Free Cell Culture Media & Supplements

circle-clipart

Recombinant

Performance Regulatory Acceptance Chemically Defined.
circle-clipart

Scalable

Supply Chain Reliability Metric Ton Capacity Global Distribution
circle-clipart

Sustainable

Animal Origin Free Reduced Carbon Footprint Made In The USA

nVitria’s portfolio of chemically defined blood-free products are used by leaders in biomanufacturing and final formulation of vaccines, biologic medicines, cell therapies, gene therapies, regenerative medicines, and diagnostics. InVitria offers a suite of recombinant protein products, each of which is completely free of human or other animal components and produced in a scalable, non-mammalian recombinant expression system at an ISO9001 certified facility in Kansas, USA.

Our customers trust us to provide safe and effective alternatives to serum and serum proteins, which are often supply chain constraints, variable from lot-to-lot, and introduce unnecessary risks of adventitious pathogen contamination. InVitria’s customers choose these products to achieve the performance and scalability they need, while also making the most sustainable choice. 

Product Categories

Gene Therapy

Cell Therapy

T-Cell Immunotherapy

Vaccine Production

Antibody Production

Food Science

Final Formulation

Product Types

Blood-Free Cell Culture Media

InVitria Complete Media: optimized, reliable, scalable performance for therapeutic applications

Serum-Free Cell Culture Media Components & Supplements

Chemically defined media, your way: optimize cell growth and performance in reduced-serum and serum-free media with individual, recombinant components

Insulin-Transferrin Cell Culture Supplements

Recombinant insulin-transferrin supplements: Optimize cell-culture performance of chemically defined media

Recombinant Human Serum Albumin

Selecting the right recombinant human albumin for your application

Recombinant Transferrin

Animal-free recombinant human transferrin for your biomanufacturing and R&D needs

Recombinant Lysozyme

Selecting the right recombinant human lysozyme for your application

Services Offered

Coming Soon....

More About InVitria

T-reg expansion in InVitria's chemically defined media: Dr. Randall Alfano

InVitria products not only provide improved patient safety in comparison to serum, but our custom media formulations give the leaders developing these T-reg therapies more control over their manufacturing system and supply chain, streamlining the regulatory approval process. 

In his presentation, Dr. Randall Alfano discusses T-reg expansion in InVitria’s chemically defined media without the use of serum or blood-derived components and why this is critical for the overall success of T-reg therapies.

 

Flyers and Product Guides

Latest Blogs

Need More Information?

The Krishgen support team strives to provide swift responses and resolution to your queries. Get in touch for a technical question, product query or quote request.

Contact Form Demo